Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FibCLOT vs RiaSTAP for Acquired Hypofibrinogenemia in Cardiac Surgery
NCT05780125Phase 2Completed
- Sponsor
- Policlinico San Donato
- Start
- Mar 2023
- Primary completion
- Feb 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Fibrinogen human in acquired hypofibrinogenemia, sponsored by Policlinico San Donato. Started Mar 2023; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
acquired hypofibrinogenemia
Beyond the preview
Go deeper on NCT05780125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05780125.